novo nordisk semaglutide oral launched an version of its GLP-1 injectable to US markets on Jan 5. Link in comments Wegovy media kit

3 The broader TRIUMPH program is evaluating retatrutide across multiple obesity-related settings, including obesity or overweight with T2D, established cardiovascular disease, knee osteoarthritis pain, moderate to severe obstructive sleep apnea, chronic low back pain, cardiovascular and renal outcomes, and metabolic dysfunction-associated steatotic liver disease

More than three-quarters dropped at least 5% of their weight, and around 30% lost 20% or more

If you must have it, eat one small slice of thin-crust veggie pizza and blot the oil with a napkin

FAQ: quick answers to common questions Do I need a doctors approval first

Ozempic doesnt distinguish. When we lose our ability to feel our hunger, we can also lose our ability to access the fire within